VEGF-话题@MedSci

#VEGF#

104篇内容 | 3070人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2209269, encodeId=274e22092690f, content=<a href='/topic/show?id=3cbe9e7892e' target=_blank style='color:#2F92EE;'>#阿尔茨海默病#</a> <a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Brain：血浆 VEGFA 和 PGF 对临床前阿尔茨海默病的纵向 tau 和认知能力的影响, objectType=article, longId=829615, objectId=3eb8829615e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679868147282_4754896.png, objectUrl=/article/show_article.do?id=3eb8829615e5, replyNumber=0, likeNumber=127, createdTime=2024-06-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3eb8829615e5, moduleTitle=Brain：血浆 VEGFA 和 PGF 对临床前阿尔茨海默病的纵向 tau 和认知能力的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eb8829615e5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1368558, encodeId=77b213685585f, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=J Clin Oncol：ICI联合VEGFR抑制剂治疗晚期肾细胞癌时的主要不良心血管事件风险, objectType=article, longId=300189, objectId=ad87300189e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad87300189e8, replyNumber=0, likeNumber=85, createdTime=2022-03-08, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad87300189e8, moduleTitle=J Clin Oncol：ICI联合VEGFR抑制剂治疗晚期肾细胞癌时的主要不良心血管事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad87300189e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368557, encodeId=20c3136855e7f, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=新型VEGFR抑制剂Fruquintinib治疗转移性结直肠癌：全球III期试验已经开始, objectType=article, longId=292042, objectId=cf0429204269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf0429204269, replyNumber=0, likeNumber=135, createdTime=2021-12-18, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf0429204269, moduleTitle=新型VEGFR抑制剂Fruquintinib治疗转移性结直肠癌：全球III期试验已经开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf0429204269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368556, encodeId=729e13685564f, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Clinical Lung Cancer：晚期非鳞状非小细胞肺癌(NSQ-NSCLC)患者化疗后培美曲塞+/-抗VEGF维持的疗效和安全性, objectType=article, longId=221343, objectId=6363221343dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6363221343dc, replyNumber=0, likeNumber=104, createdTime=2021-12-02, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6363221343dc, moduleTitle=Clinical Lung Cancer：晚期非鳞状非小细胞肺癌(NSQ-NSCLC)患者化疗后培美曲塞+/-抗VEGF维持的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6363221343dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368555, encodeId=a94b136855594, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=贝伐珠单抗对肺腺癌脑转移伴难治性脑水肿患者生活质量及血清 VEGF水平的影响, objectType=article, longId=220772, objectId=5716220e7251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5716220e7251, replyNumber=0, likeNumber=94, createdTime=2021-11-23, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5716220e7251, moduleTitle=贝伐珠单抗对肺腺癌脑转移伴难治性脑水肿患者生活质量及血清 VEGF水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5716220e7251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368554, encodeId=2f59136855499, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Clinical Lung Cancer：晚期非鳞状非小细胞肺癌(NSQ-NSCLC)患者化疗后培美曲塞+/-抗VEGF维持的疗效和安全性, objectType=article, longId=219975, objectId=348e2199e529, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=348e2199e529, replyNumber=0, likeNumber=86, createdTime=2021-11-10, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=348e2199e529, moduleTitle=Clinical Lung Cancer：晚期非鳞状非小细胞肺癌(NSQ-NSCLC)患者化疗后培美曲塞+/-抗VEGF维持的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=348e2199e529)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368553, encodeId=8dc7136855366, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Cancer Commun：一线VEGFR-TKI失败的mRCC患者中，二线axitinib联合抗PD-1抗体或axitinib单药治疗的疗效, objectType=article, longId=215476, objectId=dc262154e628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc262154e628, replyNumber=0, likeNumber=120, createdTime=2021-08-10, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc262154e628, moduleTitle=Cancer Commun：一线VEGFR-TKI失败的mRCC患者中，二线axitinib联合抗PD-1抗体或axitinib单药治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc262154e628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368552, encodeId=c08413685524f, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=NAT BIOMED ENG：朝阳医院陶勇团队等提出外泌体联合VEGF，治疗眼底新生血管性疾病, objectType=article, longId=215112, objectId=292a21511215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=292a21511215, replyNumber=0, likeNumber=127, createdTime=2021-08-02, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=292a21511215, moduleTitle=NAT BIOMED ENG：朝阳医院陶勇团队等提出外泌体联合VEGF，治疗眼底新生血管性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=292a21511215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368551, encodeId=14871368551a3, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=JAMA Ophthalmol：玻璃体内注射VEGF抑制剂阿柏西普对糖尿病视网膜病变视力减退的预防作用, objectType=article, longId=209409, objectId=ebae2094096b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebae2094096b, replyNumber=0, likeNumber=102, createdTime=2021-04-05, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebae2094096b, moduleTitle=JAMA Ophthalmol：玻璃体内注射VEGF抑制剂阿柏西普对糖尿病视网膜病变视力减退的预防作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebae2094096b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368550, encodeId=dfd813685500f, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=JCI Insight：VEGF-A165基因治疗可改善血-迷路屏障破裂和听力损失 , objectType=article, longId=209295, objectId=f1b5209295f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1b5209295f3, replyNumber=0, likeNumber=131, createdTime=2021-04-02, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1b5209295f3, moduleTitle=JCI Insight：VEGF-A165基因治疗可改善血-迷路屏障破裂和听力损失 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1b5209295f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368549, encodeId=b508136854901, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=等待15年的突破！双特异性抗体革新眼科anti-VEGF疗法，每4个月注射1次, objectType=article, longId=207282, objectId=c52520e282da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c52520e282da, replyNumber=0, likeNumber=108, createdTime=2021-02-20, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c52520e282da, moduleTitle=等待15年的突破！双特异性抗体革新眼科anti-VEGF疗法，每4个月注射1次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c52520e282da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368548, encodeId=8d42136854836, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=靶向VEGF / DLL4的双特异性抗体TR009 / ABL001治疗消化道肿瘤，临床前结果喜人, objectType=article, longId=205445, objectId=4f8a20544515, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f8a20544515, replyNumber=0, likeNumber=98, createdTime=2021-01-09, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f8a20544515, moduleTitle=靶向VEGF / DLL4的双特异性抗体TR009 / ABL001治疗消化道肿瘤，临床前结果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f8a20544515)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368547, encodeId=10c0136854e9a, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=JNNP：POEMS综合征早期VEGF检测可避免POEMS综合征的误诊和相关费用, objectType=article, longId=203279, objectId=f43f2032e947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f43f2032e947, replyNumber=0, likeNumber=109, createdTime=2020-11-13, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f43f2032e947, moduleTitle=JNNP：POEMS综合征早期VEGF检测可避免POEMS综合征的误诊和相关费用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f43f2032e947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368546, encodeId=e99c136854658, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=PD-L1单抗Tecentriq联合VEGF单抗Avastin：在中国获准治疗常见的肝癌患者, objectType=article, longId=202660, objectId=e6f9202660eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6f9202660eb, replyNumber=0, likeNumber=109, createdTime=2020-10-31, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6f9202660eb, moduleTitle=PD-L1单抗Tecentriq联合VEGF单抗Avastin：在中国获准治疗常见的肝癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6f9202660eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368545, encodeId=49e41368545a8, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Nat Commun：VEGF受体疫苗在2型神经纤维瘤病中显示出初步疗效, objectType=article, longId=201446, objectId=e59d20144641, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e59d20144641, replyNumber=0, likeNumber=151, createdTime=2020-10-02, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e59d20144641, moduleTitle=Nat Commun：VEGF受体疫苗在2型神经纤维瘤病中显示出初步疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e59d20144641)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368544, encodeId=a19d136854483, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=新型VEGFR抑制剂Fruquintinib治疗转移性结直肠癌：全球III期试验已经开始, objectType=article, longId=200275, objectId=54442002e505, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54442002e505, replyNumber=0, likeNumber=130, createdTime=2020-09-06, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54442002e505, moduleTitle=新型VEGFR抑制剂Fruquintinib治疗转移性结直肠癌：全球III期试验已经开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54442002e505)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368543, encodeId=0c861368543f1, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Blood：VEGF-C可保护骨髓血管周围微环境的完整性, objectType=article, longId=200213, objectId=01a9200213e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01a9200213e7, replyNumber=0, likeNumber=131, createdTime=2020-09-05, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01a9200213e7, moduleTitle=Blood：VEGF-C可保护骨髓血管周围微环境的完整性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01a9200213e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368542, encodeId=763b1368542cb, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=VEGF-C/D（Opthea）和VEGF-A的双重靶向抑制：2a期临床证实显著提高糖尿病性视网膜病变患者的视力, objectType=article, longId=195644, objectId=8db11956440c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8db11956440c, replyNumber=0, likeNumber=144, createdTime=2020-06-12, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8db11956440c, moduleTitle=VEGF-C/D（Opthea）和VEGF-A的双重靶向抑制：2a期临床证实显著提高糖尿病性视网膜病变患者的视力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8db11956440c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368541, encodeId=24d9136854141, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Cell Death Dis：正反馈通路SNAIL/miR590/VEGFR/NRP1促进胃癌发生发展, objectType=article, longId=192883, objectId=fd0a1928834e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd0a1928834e, replyNumber=0, likeNumber=110, createdTime=2020-04-25, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd0a1928834e, moduleTitle=Cell Death Dis：正反馈通路SNAIL/miR590/VEGFR/NRP1促进胃癌发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd0a1928834e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368540, encodeId=c4561368540f1, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=VEGFR抑制剂Cediranib联合PARP抑制剂Lynparza治疗铂敏感复发性卵巢癌的III期试验失败, objectType=article, longId=190019, objectId=8870190019fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8870190019fe, replyNumber=0, likeNumber=71, createdTime=2020-03-16, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8870190019fe, moduleTitle=VEGFR抑制剂Cediranib联合PARP抑制剂Lynparza治疗铂敏感复发性卵巢癌的III期试验失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8870190019fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

VEGF

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#阿尔茨海默病# #VEGF#

Brain：血浆 VEGFA 和 PGF 对临床前阿尔茨海默病的纵向 tau 和认知能力的影响

2024-06-10发表于上海

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

J Clin Oncol：ICI联合VEGFR抑制剂治疗晚期肾细胞癌时的主要不良心血管事件风险

2022-03-08

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

新型VEGFR抑制剂Fruquintinib治疗转移性结直肠癌：全球III期试验已经开始

2021-12-18

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Clinical Lung Cancer：晚期非鳞状非小细胞肺癌(NSQ-NSCLC)患者化疗后培美曲塞+/-抗VEGF维持的疗效和安全性

2021-12-02

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

贝伐珠单抗对肺腺癌脑转移伴难治性脑水肿患者生活质量及血清 VEGF水平的影响

2021-11-23

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Clinical Lung Cancer：晚期非鳞状非小细胞肺癌(NSQ-NSCLC)患者化疗后培美曲塞+/-抗VEGF维持的疗效和安全性

2021-11-10

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Cancer Commun：一线VEGFR-TKI失败的mRCC患者中，二线axitinib联合抗PD-1抗体或axitinib单药治疗的疗效

2021-08-10

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

NAT BIOMED ENG：朝阳医院陶勇团队等提出外泌体联合VEGF，治疗眼底新生血管性疾病

2021-08-02

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

JAMA Ophthalmol：玻璃体内注射VEGF抑制剂阿柏西普对糖尿病视网膜病变视力减退的预防作用

2021-04-05

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

JCI Insight：VEGF-A165基因治疗可改善血-迷路屏障破裂和听力损失

2021-04-02

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

等待15年的突破！双特异性抗体革新眼科anti-VEGF疗法，每4个月注射1次

2021-02-20

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

靶向VEGF / DLL4的双特异性抗体TR009 / ABL001治疗消化道肿瘤，临床前结果喜人

2021-01-09

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

JNNP：POEMS综合征早期VEGF检测可避免POEMS综合征的误诊和相关费用

2020-11-13

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

PD-L1单抗Tecentriq联合VEGF单抗Avastin：在中国获准治疗常见的肝癌患者

2020-10-31

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Nat Commun：VEGF受体疫苗在2型神经纤维瘤病中显示出初步疗效

2020-10-02

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

新型VEGFR抑制剂Fruquintinib治疗转移性结直肠癌：全球III期试验已经开始

2020-09-06

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Blood：VEGF-C可保护骨髓血管周围微环境的完整性

2020-09-05

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

VEGF-C/D（Opthea）和VEGF-A的双重靶向抑制：2a期临床证实显著提高糖尿病性视网膜病变患者的视力

2020-06-12

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Cell Death Dis：正反馈通路SNAIL/miR590/VEGFR/NRP1促进胃癌发生发展

2020-04-25

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

VEGFR抑制剂Cediranib联合PARP抑制剂Lynparza治疗铂敏感复发性卵巢癌的III期试验失败

2020-03-16

科室
- - 订阅+
  - 更多科室
工具
服务